{"symbol":"LLY","fiscalQuarter":"Q3-2012","reportDate":"2012-10-24","reportTime":"BMO","status":"reported","company":{"name":"Eli Lilly and Company","sector":"Health Care","industry":"Pharmaceuticals"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/LLY/earnings/Q3-2012","postBrief":{"headline":"Eli Lilly Misses on EPS, Stock Down 2.72%","keyNumbers":[{"metric":"EPS","actual":"$0.79","expected":"N/A","surprise":"-4.59%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Unknown","keyQuotes":[],"summary":"No transcript is on record, and the analysis is based solely on numerical results."},"guidanceChanges":{"summary":"No guidance data is available.","changes":[]},"whatItMeans":"Eli Lilly's earnings report showed a slight miss on EPS, which led to a 2.72% decline in the stock price. Investors may be concerned about the company's performance, especially since no revenue figures or guidance updates were provided. The lack of additional context from management could contribute to uncertainty among investors.","metaDescription":"Eli Lilly (LLY) Q3 2012 earnings: EPS missed expectations. Stock down 2.72%. Full breakdown."}}